89 results
8-K
EX-10.1
PLXPQ
PLx Pharma Winddown Corp.
26 May 23
Entry into a Material Definitive Agreement
4:19pm
8-K
EX-10.1
PLXPQ
PLx Pharma Winddown Corp.
12 Apr 23
PLx Pharma Inc. Enters into a Stalking Horse Asset Purchase Agreement to Sell VAZALORE® and Substantially All of its Assets
5:29pm
8-K
EX-10.1
PLXPQ
PLx Pharma Winddown Corp.
13 Feb 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:16pm
8-K
EX-10.5
PLXPQ
PLx Pharma Winddown Corp.
13 Feb 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:16pm
8-K
EX-10.2
PLXPQ
PLx Pharma Winddown Corp.
13 Feb 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:16pm
8-K
EX-10.3
gvbqu01 kl5
13 Feb 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:16pm
8-K
EX-10.4
cmnt 928f93m
13 Feb 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:16pm
8-K
EX-10.1
grnrseyy1d y3vkx
2 Mar 21
PLX Pharma Inc. Announces Proposed Public Offering of Common Stock
4:16pm
8-K
EX-10.3
8u71li8v
16 Nov 20
PLx Pharma Inc. Reports Third Quarter 2020 Results and Provides Business Update
4:18pm
8-K
EX-10.2
a8zipyri642plaztc
16 Nov 20
PLx Pharma Inc. Reports Third Quarter 2020 Results and Provides Business Update
4:18pm
8-K
EX-10.1
at9ga ltop1
16 Nov 20
PLx Pharma Inc. Reports Third Quarter 2020 Results and Provides Business Update
4:18pm
8-K
EX-10.2
398 tknihv0tz9a
13 Mar 20
PLx Pharma Inc. Reports Fourth Quarter2019Results and Provides Regulatory Update on VAZALORE
7:32am
8-K
EX-10.1
zhwhu51t329y
13 Mar 20
PLx Pharma Inc. Reports Fourth Quarter2019Results and Provides Regulatory Update on VAZALORE
7:32am
DEFA14A
EX-10.1
f21rr6clc9ms1lzlwp1
13 Mar 20
Additional proxy soliciting materials
7:30am
DEFA14A
EX-10.2
0h9uums
13 Mar 20
Additional proxy soliciting materials
7:30am